BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28656213)

  • 1. BMH-21 inhibits viability and induces apoptosis by p53-dependent nucleolar stress responses in SKOV3 ovarian cancer cells.
    Fu X; Xu L; Qi L; Tian H; Yi D; Yu Y; Liu S; Li S; Xu Y; Wang C
    Oncol Rep; 2017 Aug; 38(2):859-865. PubMed ID: 28656213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acrolein preferentially damages nucleolus eliciting ribosomal stress and apoptosis in human cancer cells.
    Wang HT; Chen TY; Weng CW; Yang CH; Tang MS
    Oncotarget; 2016 Dec; 7(49):80450-80464. PubMed ID: 27741518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells.
    Sasaki H; Sheng Y; Kotsuji F; Tsang BK
    Cancer Res; 2000 Oct; 60(20):5659-66. PubMed ID: 11059757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
    Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
    Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells.
    Fraser M; Chan SL; Chan SS; Fiscus RR; Tsang BK
    Oncogene; 2006 Apr; 25(15):2203-12. PubMed ID: 16288207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An anthraquinone derivative from Luffa acutangula induces apoptosis in human lung cancer cell line NCI-H460 through p53-dependent pathway.
    Vanajothi R; Srinivasan P
    J Recept Signal Transduct Res; 2016; 36(3):292-302. PubMed ID: 26585176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TBMS1 exerts its cytotoxicity in NCI-H460 lung cancer cells through nucleolar stress-induced p53/MDM2-dependent mechanism, a quantitative proteomics study.
    Lin Y; Xie G; Xia J; Su D; Liu J; Jiang F; Xu Y
    Biochim Biophys Acta; 2016 Feb; 1864(2):204-10. PubMed ID: 26549658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling.
    Watson JL; Greenshields A; Hill R; Hilchie A; Lee PW; Giacomantonio CA; Hoskin DW
    Mol Carcinog; 2010 Jan; 49(1):13-24. PubMed ID: 19676105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Wnt Target Protein Peter Pan Defines a Novel p53-independent Nucleolar Stress-Response Pathway.
    Pfister AS; Keil M; Kühl M
    J Biol Chem; 2015 Apr; 290(17):10905-18. PubMed ID: 25759387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic effect of piperine and paclitaxel on cell fate via cyt-c, Bax/Bcl-2-caspase-3 pathway in ovarian adenocarcinomas SKOV-3 cells.
    Pal MK; Jaiswar SP; Srivastav AK; Goyal S; Dwivedi A; Verma A; Singh J; Pathak AK; Sankhwar PL; Ray RS
    Eur J Pharmacol; 2016 Nov; 791():751-762. PubMed ID: 27756602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
    Hastak K; Gupta S; Ahmad N; Agarwal MK; Agarwal ML; Mukhtar H
    Oncogene; 2003 Jul; 22(31):4851-9. PubMed ID: 12894226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nuclear mitotic apparatus protein NuMA controls rDNA transcription and mediates the nucleolar stress response in a p53-independent manner.
    Jayaraman S; Chittiboyina S; Bai Y; Abad PC; Vidi PA; Stauffacher CV; Lelièvre SA
    Nucleic Acids Res; 2017 Nov; 45(20):11725-11742. PubMed ID: 28981686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between p53 protein phosphorylation at serine 15, serine 20 and sensitivity of cells isolated from patients with ovarian cancer and cell lines to chemotherapy in in vitro study.
    Kamińska I; Bar JK
    Pharmacol Rep; 2018 Jun; 70(3):570-576. PubMed ID: 29684847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleolar stress with and without p53.
    James A; Wang Y; Raje H; Rosby R; DiMario P
    Nucleus; 2014; 5(5):402-26. PubMed ID: 25482194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The HBx protein of hepatitis B virus confers resistance against nucleolar stress and anti-cancer drug-induced p53 expression.
    Kapoor NR; Ahuja R; Shukla SK; Kumar V
    FEBS Lett; 2013 May; 587(9):1287-92. PubMed ID: 23507139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emodin induces a reactive oxygen species-dependent and ATM-p53-Bax mediated cytotoxicity in lung cancer cells.
    Lai JM; Chang JT; Wen CL; Hsu SL
    Eur J Pharmacol; 2009 Nov; 623(1-3):1-9. PubMed ID: 19744477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line.
    Vaskivuo L; Rysä J; Koivuperä J; Myllynen P; Vaskivuo T; Chvalova K; Serpi R; Savolainen ER; Puistola U; Vähäkangas K
    Toxicol Appl Pharmacol; 2006 Oct; 216(1):89-97. PubMed ID: 16797627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates modulate the expression of p53-MYCN associated micro RNAs in neuroblastoma cells and cause cell cycle arrest and apoptosis.
    Ramaiah MJ; Pushpavalli SN; Lavanya A; Bhadra K; Haritha V; Patel N; Tamboli JR; Kamal A; Bhadra U; Pal-Bhadra M
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5699-706. PubMed ID: 23992861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wild-type p53 breast cancer cells.
    Geng QQ; Dong DF; Chen NZ; Wu YY; Li EX; Wang J; Wang SM
    Int J Oncol; 2013 Dec; 43(6):1935-42. PubMed ID: 24126697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic interaction between the novel histone deacetylase inhibitor ST2782 and the proteasome inhibitor bortezomib in platinum-sensitive and resistant ovarian carcinoma cells.
    Gatti L; Benedetti V; De Cesare M; Corna E; Cincinelli R; Zaffaroni N; Zunino F; Perego P
    J Inorg Biochem; 2012 Aug; 113():94-101. PubMed ID: 22717676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.